Significant results typically develop over 3-6 months of consistent treatment
An app that only shows the number on the scale cannot tell you if the pace is safe
Not recommended in case of kidney, heart and cardiovascular disease, neither for people who suffer from diseases accompanied with seizures
Over the last several years, GLP-1 prescriptions have surged because these drugs are widely discussed not only for diabetes control but also for weight loss and long-term chronic weight management, including use patterns that expanded public awareness and demand

Examples Type 2 diabetes on long-term insulin therapy E11.x + Z79.4 Use Z79.84 when documentation shows that the patient is taking ongoing oral diabetes medications , such as: Metformin Sulfonylureas DPP-4 inhibitors SGLT2 inhibitors Thiazolidinediones GLP-1 receptor agonists (if oral formulation) When to Use Z79.84 Z79.84 applies when: The patient uses oral medication as part of long-term management Medication refills, adjustments, or follow-ups are documented The provider indicates continued pharmacologic therapy Example T2DM managed with metformin E11.x + Z79.84 When a patient uses both insulin and oral medications , assign both codes: Z79.4 Long-term insulin Z79.84 Long-term oral medications Example Type 2 diabetes treated with metformin and long-term insulin E11.x + Z79.4 + Z79.84 Although type 1 patients rely on insulin, Z79.4 is not assigned with Type 1 diabetes